Danaher Corporation

American conglomerate

Follow Danaher Corporation on Notably News to receive short updates to your email — rarely!

June 2024 The US Food and Drug Administration (FDA) granted marketing approval to Danaher's Cepheid unit for a rapid hepatitis C test that can detect virus RNA from a fingertip blood sample in less than an hour.
April 2024 Precision Nanosystems was merged into Cytiva.
September 30 2023 Danaher completed the separation of Veralto, which began trading on the New York Stock Exchange on October 2 under the symbol 'VLTO'.
September 19 2023 Cepheid and Danaher announce a 20% price reduction for their Xpert MTB/RIF TB test cartridge, lowering the price from $9.98 to $7.97 in high TB-burden countries, following public pressure.
September 12 2023 Author and vlogger John Green releases a video raising ethical concerns about the pricing of Cepheid's test cartridges and mobilizes his community to take action against Danaher.
August 28 2023 Danaher entered into a definitive agreement to acquire Abcam for approximately $5.7 billion at $24 per share in cash.
February 8 2023 Danaher announced the new spun-off company would be named Veralto Corporation, to be led by Jennifer Honeycutt as President and CEO.
September 2022 Danaher announced its intention to spin off the Environmental & Applied Solutions segment in Q4 2023.
September 2022 Danaher announced the merger of Pall Life Sciences with Cytiva to create a new Biotechnology Group, which was completed in May 2023.
September 1 2020 Rainer Blair replaced Tom Joyce as CEO of Danaher Corporation.
May 2020 Announcement made that Tom Joyce would retire as CEO of the company.
March 2020 Danaher acquired the biopharma business of General Electric Life Sciences division for $21.4 billion, renamed Cytiva.
March 2 2020 FDA Commissioner Dr. Stephen Hahn referenced Integrated DNA Technologies (a Danaher division) in discussing expanded coronavirus testing capacity.
2019 Treatment Action Group and Doctors Without Borders begin advocating for Cepheid to lower the prices of disease test cartridges for COVID-19, HIV, and tuberculosis.
October 2019 Danaher announced it would sell its biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards businesses to Sartorius AG for approximately $750 million.
July 2018 Danaher announced its intention to spin off its $2.8 billion Dental segment into an independent publicly traded company, with Amir Aghdaei to be President and CEO of the new company.
March 2018 Danaher announced it would acquire Integrated DNA Technologies for an undisclosed price.
October 2017 Danaher announced the acquisition of scientific informatics company ID Business Solutions Ltd. (IDBS), which would become part of Danaher's Life Sciences platform.
October 2016 Danaher Corporation acquired Phenomenex for $700 million to expand its life sciences space.
September 2016 Danaher announced it would acquire Cepheid for $4 billion (including debt).
June 2016 Danaher spun off several subsidiaries, including Matco and AMMCO-COATS, to create Fortive.
May 2015 Danaher announced the acquisition of Pall Corporation for $13.8 billion, completed in August 2015.
October 2014 Danaher Corp announced it would be combining its communications unit with NetScout Systems, which was completed in July 2015.
September 2014 Danaher announced its intention to buy Nobel Biocare for $2.2 billion.
December 2012 Danaher Corporation acquired Navman Wireless, a provider of on-demand fleet and asset management technology.
October 2012 Danaher and Cooper Industries agreed to sell their joint venture, Apex Tool Group, to Bain Capital for approximately $1.6 billion.
2011 Danaher acquired Beckman Coulter and sold Accu-sort to Datalogic.

This contents of the box above is based on material from the Wikipedia article Danaher Corporation, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.

See Also